Dr. Michael Peter Combs, MD

Dr. Combs practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Combs' NPI, 1144663501, was assigned on April 16, 2013. Dr. Combs holds Michigan license 4301109919.

Dr. Combs' primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Combs' primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Combs to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Combs practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Combs' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Combs' licenses on file in 2 states: Michigan and California.

CMS data shows 160 Medicare services from Dr. Combs across 6 procedure codes in 2024, for 61 Medicare patients. Medicare paid $12,240 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Combs in 2024. The largest group is under 65, with 24 patients. 67% of them have high blood pressure, and 59% have high cholesterol. 25% are also on Medicaid. Their average risk score is 3.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Combs' median patient age at 65, with 50% women.

In 2024, Dr. Combs wrote 620 Medicare Part D claims for 54 patients. 77% of them were for generic drugs. CMS names the drug for 380 of them, across 16 drugs with 11 or more claims each, at $247,118 in total drug cost. In 2023, CMS named 464 claims across 21 drugs.

Dr. Combs accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Combs from 3 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 90% of the total. Sanofi and Genzyme US Companies paid the most, $2,627. It also lists 9 research payments totaling $1,413 in 2024, naming 1 clinical trial.